NSC-691236
N/A
Report date: 2022/07/04 19:38:02
Base Information
Drug NameNSC-691236
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Medical Center FreiburgNational Cancer InstituteUniversity Of Maryland, Baltimore
Active IndicationsN/A
Inactive Indications +[8]
Other Information
ATC CodeN/A
Related LinksN/A